PVIVAX Knowledge sharing for relapsing malaria
P. vivax malaria studies: A database of studies focusing on improving access to radical cure.
About the P. vivax information hub.
A short film highlighting the work of the Tafenoquine Roll-out STudy (TRuST) in Brazil. This study was co-sponsored by the Brazilian Ministry of Health (MoH) and Medicines for Malaria Venture (MMV). Film directed and produced by Hungry Man.
PAVE is conducting feasibility studies and operational research to support Ministries of Health in malaria endemic countries to look at the best way to use different P. vivax relapse treatments and diagnostics at different levels of the healthcare system in support of their elimination goals.
The Brazilian Ministry of Health (MoH) and MMV, are conducting a study to understand the feasibility of providing appropriate radical cure treatment (primaquine - PQ - or tafenoquine – TQ) based on the results of G6PD testing conducted in real-world settings.
This short film introduces the 'ARCTIC' feasibility study in Thailand. A study looking at the operational feasibility of using quantitative G6PD testing prior to treatment for Plasmodium vivax malaria relapse with tafenoquine or primaquine.
This paper outlines the process of OAT development in detail to inform relevant stakeholders and assist other researchers developing similar toolkit/s in other settings for malaria or for other diseases.
This study aims to analyse the association of G6PDd and anaemia in malaria patients receiving anti-malarial drugs.
This study analyzes the currently recommended adult dose of tafenoquine and concludes it is insufficient for radical cure in all adults.
This is the protocol for a multicentre, health care facility-based, randomized, controlled, open-label trial ongoing in Bangladesh, Indonesia and Ethiopia. The study is evaluating the potential benefit of a universal radical cure for both P. vivax and P. falciparum in different endemic locations.